or
forgot password

Protocol to Obtain Blood Samples for Leukemia Research


N/A
18 Years
N/A
Open (Enrolling)
Both
Chronic Lymphocytic Leukemia

Thank you

Trial Information

Protocol to Obtain Blood Samples for Leukemia Research


The blood sample will be used in the laboratory to perform studies focusing on Chronic
Lymphocytic Leukemia (CLL).


Inclusion Criteria:



- Patients undergoing routine blood draws as part of their ongoing follow-up for
Chronic Lymphocytic Leukemia (CLL) at the Norris Cotton Cancer Center of DHMC.

Exclusion Criteria:

- Patients who have received cytotoxic drug, oral or intravenous steroid or targeted
antibody therapy for CLL or other disease process within the past 6 months are
excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To determine the frequency with which CLL cells incubated ex vivo with vincristine undergo rapid interphase apoptosis.

Outcome Time Frame:

2 Years

Safety Issue:

No

Principal Investigator

Christopher H Lowrey, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dartmouth-Hitchcock Medical Center

Authority:

United States: Institutional Review Board

Study ID:

D0905

NCT ID:

NCT00889031

Start Date:

April 2009

Completion Date:

April 2015

Related Keywords:

  • Chronic Lymphocytic Leukemia
  • CLL
  • Leukemia
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, Lymphoid

Name

Location
Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire  03756